| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |